A quiet change in North Dakota law gives pharmacists new authority to swap medications—and shifts how prescribers and pharmacies will need to coordinate.
Most prescribers in North Dakota don't yet realize that their authority over medication dispensing just changed. Under SB2402, pharmacists can now substitute a therapeutically equivalent drug in place of what you prescribed—without asking permission first.
Here's what actually happened, why it matters, and what you need to know.
Section 4 of SB2402 (Page 8) created a new dispensing authority for pharmacists. Instead of calling your office to request approval before swapping a brand-name drug for a generic equivalent or switching between therapeutically equivalent options, a pharmacist can now make that substitution independently. The only requirement: the pharmacist must notify you electronically within 24 hours after the substitution occurs.
The law took effect upon filing with the Secretary of State (Section 7, Page 9).
This isn't about swapping unrelated drugs. Therapeutically equivalent means the substitute drug is expected to produce the same clinical result and safety profile as the original prescription. In practice, this covers most generic-to-brand and brand-to-generic switches, plus some switches between different drugs in the same class when they're deemed equivalent by established standards.
The key shift: the pharmacist decides whether equivalence applies. Your input is no longer required upfront.
Independent pharmacies and small pharmacy chains feel this change most directly. They now have new discretion over dispensing decisions that were previously prescriber-controlled. For prescribers—especially those in solo or small-group practices—this means a new workflow: monitoring electronic notifications from pharmacies and managing cases where a substitution wasn't what you intended.
Larger health systems with integrated pharmacy operations may experience less disruption, since they often already coordinate substitutions internally.
You'll need to monitor pharmacy notifications within 24 hours of dispensing. If a substitution wasn't appropriate for a specific patient—due to allergies, interactions, or clinical reasons—you'll need a process to catch and correct it quickly. The law explicitly states that prescribers bear no liability for substitutions made under this authority, which means the responsibility and risk sit with the pharmacist and pharmacy.
This also affects your relationship with patients. Some may receive a different medication than they expected without your prior sign-off, which can create confusion or concern. Clear communication with your pharmacy partners about which drugs should never be substituted—and why—becomes more important.
For practices that rely on specific brand formulations or have patients with narrow therapeutic windows, documenting "do not substitute" instructions becomes a critical safeguard.
Review your current pharmacy relationships and clarify which medications, if any, should never be substituted without your approval. Establish a simple system for reviewing those 24-hour notifications. If you work with multiple pharmacies, make sure each understands your preferences.
The law is already in effect. The operational adjustment is yours to manage.
For a detailed breakdown of SB2402's full text and section-by-section summary, a free resource guide is available through the North Dakota Pharmacists Association and state medical board resources.